Quinn Bio
Your biopharma team
Quinn is a biopharma team engaged for work across discovery, development, portfolio and commercial strategy. It conducts research, analyzes data, builds models, and designs molecules and studies, delivering a comprehensive report alongside the underlying work, with evidence, methods and assumptions made clear. Results arrive in 3–5 days after the work is approved.
Capabilities span target assessment, computational molecule and protein design, biomarkers, patient populations, dose strategy, trial design and analysis, safety, regulatory strategy, manufacturing and supply, portfolio prioritization and valuation scenarios, licensing and acquisition due diligence, and commercial and medical strategy including positioning, pricing, market access and launch planning. Deliverables include an executive summary, detailed assessment sections, and supporting analyses, models, computational designs and reproducible code. Quinn runs on AWS with encryption in transit and at rest; iollo, Inc. holds ISO/IEC 27001:2022 certification, its SOC 2 Type II report covers Quinn, and a HIPAA BAA is available. Project data is not used to train models.
Work is scoped per engagement: you describe the problem, review the proposed scope and deliverables, and approve before the run begins. Pricing, plans and packaging are not specified on these pages.
12 alternatives to Quinn Bio
Ranked by how well each tool replaces Quinn Bio: shared features, audience, price and popularity.
- 61 out of 100 matchUsage-based
Accelerate biologics discovery with cutting-edge bioinformatics
Covers 0 of 15 key features.
59 out of 100 matchContact sales- 57 out of 100 match—
- 57 out of 100 matchContact sales
The real-time search engine for AI agents
Covers 5 of 15 key features and has a free plan.
Free plan56 out of 100 matchFreeWeb infrastructure for AI to search, extract, monitor, and reason over the world's info.
Covers 6 of 15 key features and has a free plan.
Free plan56 out of 100 matchFree- 55 out of 100 matchContact sales
CRISPR gene modulation and AI for cancer and inflammation treatments
Covers 9 of 15 key features.
55 out of 100 match—- 55 out of 100 matchContact sales
Trusted AI built on 175 years of Thomson Reuters knowledge
Covers 6 of 15 key features.
55 out of 100 match—AI research agent for quantitative finance that plans and executes multi-step analyses and
Covers 7 of 15 key features and has a free plan.
Free plan55 out of 100 match$50/mo- 54 out of 100 match—